VENUS REMEDIES
|
The Current P/E Ratio of VENUS REMEDIES is 14.07.
Share Price | ₹304.9 | Mar 27,2024 |
Market Cap | ₹408.6 Cr | |
Earnings-TTM | ₹29.0 Cr | TTM-Consolidated Results |
Price/Earnings | 14.07x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of VENUS REMEDIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹408.6 Cr] as on Mar 27,2024
(/) Earnings [ ₹29.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 14.07x ]
Thus, for VENUS REMEDIES , the investors are currently willing to pay 14.07 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of VENUS REMEDIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of VENUS REMEDIES over the last five years.
Historical PE (Price/Earnings) ratio chart of VENUS REMEDIES
PE Ratio Performance Analysis for VENUS REMEDIES
- VENUS REMEDIES 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 4.49x.
- VENUS REMEDIES 's operated at median p/e ratio of 5.49x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, VENUS REMEDIES 's p/e ratio peaked in Mar2022 at 8.82x.
- VENUS REMEDIES 's p/e ratio hit its five-year low in Mar2020 of 0x.
How does VENUS REMEDIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
VENUS REMEDIES | 29.03 | 14.07 | 408.6 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 8,998.63 | 42.88 | 385,837.0 |
DIVIS LABORATORIES LTD | 1,382.97 | 64.59 | 89,323.5 |
CIPLA LTD | 3,744.03 | 31.62 | 118,376.0 |
DR REDDYS LABORATORIES LTD | 5,209.40 | 19.37 | 100,885.0 |
TORRENT PHARMACEUTICALS LTD | 1,494.00 | 58.09 | 86,779.1 |
ABBOTT INDIA LTD | 1,145.58 | 49.62 | 56,838.6 |
ZYDUS LIFESCIENCES LTD | 2,954.20 | 34.05 | 100,583.0 |
ALKEM LABORATORIES LTD | 1,574.66 | 37.96 | 59,770.5 |
LUPIN LTD | 1,809.74 | 40.24 | 72,826.6 |
BIOCON LTD | 1,611.00 | 19.12 | 30,807.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs VENUS REMEDIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 14.07x |
Max industry PE | 64.59x |
Median industry PE | 37.96x |
Average industry PE | 37.42x |
You may also like the below Video Courses